Clorox (CLX) PT Lowered to $195 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 4/23/2024
- Wall St stocks end higher with major corporate earnings in view
- SAP Q1 results fall short of Wall Street estimates as transformation kicks off
- Cadence (CDNS) tumbles despite Q1 beat on top and bottom lines
- Tesla expands price cuts to China, Germany after reducing FSD cost; shares down
- Gold prices slide as M.East fears ease, rate jitters persist
- Fisker (FSR) Appoints Michael Healy as Chief Restructuring Officer
- Kroger (KR), Albertsons and C&S Wholesale Grocers Announce an Updated and Expanded Divestiture Plan
- Costar Group (CSGP) to Acquire Matterport (MTTR) for $5.50/sh Cash and Stock
- Apple (AAPL) PT Lowered to $210 at Morgan Stanley, 'We'd buy post-earnings weakness'
- Jaguar Health (JAGX) Files $75M Mixed Shelf
- After-hours movers: Cadence Design Systems, Cleveland-Cliffs, Riot Platforms, and more
- Midday movers: Tesla, Li Auto and CNH Industrial fall; Salesforce rises
- Midday movers: Netflix, Super Micro fall; Paramount Global gains
- After-hours movers: Netflix, Intuitive Surgical, Nordstrom, KB Home
- Midday movers: Tesla, Blackstone, Las Vegas Sands fall; DR Horton rises
Clorox to Present at Upcoming RBC, Bernstein and dbAccess Investor Conferences
May 3, 2021 6:30 AM EDTOAKLAND, Calif., May 3, 2021 /PRNewswire/ -- The Clorox Company (NYSE: CLX) announced today that its chief executive officer and chief financial officer will be featured speakers at three investor conferences to be held next month.
June 2 RBC Capital Markets Global Consumer and Retail Virtual Conference: CEO Linda Rendle to speak at 11:20 a.m. ET/8:20 a.m. PT37th Annual Bernstein Strategic Decisions Virtual Conference: CFO Kevin Jacobsen to speak at 1:30 p.m. ET/10:30 a.m. PT.
June 9 dbAccess Global Consumer Virtual... More
Clorox Reports Q3 Fiscal Year 2021 Results, Updates Fiscal Year Outlook
April 30, 2021 6:30 AM EDTOAKLAND, Calif., April 30, 2021 /PRNewswire/ --Â In its fiscal third quarter ending March 31, 2021, The Clorox Company (NYSE: CLX) reported flat sales and diluted net loss per share (diluted EPS) of 49 cents, a 126% decrease compared to the year-ago quarter.
GAAP earnings per share reflect a pre-tax noncash impairment charge of $329 million (or $2.11 diluted EPS). The impairment charge is the result of an adjustment to the carrying values of goodwill, trademarks and other assets in the Better Health Vitamins, Minerals and Supplements (VMS) business. On an adjusted basis, Clorox delivered diluted net earnings... More
